Insider Transactions in Q4 2024 at Revance Therapeutics, Inc. (RVNC)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 18
2024
|
David Hollander CMO & Global Therapeutics Lead |
SELL
Open market or private sale
|
Direct |
3,908
-3.59%
|
$15,632
$4.17 P/Share
|